Cargando…
Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
Acute lung injury and acute respiratory distress syndrome (ARDS) are characterised by severe hypoxemic respiratory failure and poor lung compliance. Despite advances in clinical management, morbidity and mortality remains high. Supportive measures including protective lung ventilation confer a survi...
Autores principales: | Dushianthan, Ahilanandan, Cusack, Rebecca, Goss, Victoria, Postle, Anthony D, Grocott, Mike PW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672556/ https://www.ncbi.nlm.nih.gov/pubmed/23171712 http://dx.doi.org/10.1186/cc11512 |
Ejemplares similares
-
Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012) -
Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014) -
Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2018) -
Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014) -
Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2019)